PUBLISHER: The Business Research Company | PRODUCT CODE: 1942817
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942817
Endovascular aneurysm repair (EVAR) devices are sophisticated medical instruments used for the minimally invasive treatment of aneurysms, particularly in the aorta. An aneurysm occurs when a part of a blood vessel wall weakens and bulges, creating a risk of rupture. EVAR devices are designed to prevent rupture by reinforcing the blood vessel and rerouting blood flow away from the weakened area.
The primary types of aneurysms addressed by EVAR devices are abdominal aortic aneurysms (AAA), thoracic aortic aneurysms (TAA), and peripheral aneurysms. An abdominal aortic aneurysm (AAA) refers to an abnormal bulge or dilation in the lower section of the aorta, the body's largest blood vessel that runs through the abdomen. EVAR devices are used with endovascular grafts, stent-grafts, catheters, delivery systems, and imaging systems, and are intended for various end users, including hospitals, ambulatory surgical centers, and specialty clinics.
Tariffs are impacting the endovascular aneurysm repair devices market by increasing costs of imported specialty alloys, stent materials, catheters, delivery systems, and advanced imaging components. Hospitals and surgical centers in North America and Europe are most affected due to reliance on imported high-precision vascular devices, while Asia-Pacific faces cost pressures on manufacturing and exporting EVAR systems. These tariffs are increasing procedure costs and affecting procurement budgets. However, they are also encouraging localized production, regional supplier development, and innovation in cost-efficient endovascular repair technologies.
The endovascular aneurysm repair devices market research report is one of a series of new reports from The Business Research Company that provides endovascular aneurysm repair devices market statistics, including endovascular aneurysm repair devices industry global market size, regional shares, competitors with a endovascular aneurysm repair devices market share, detailed endovascular aneurysm repair devices market segments, market trends and opportunities, and any further data you may need to thrive in the endovascular aneurysm repair devices industry. This endovascular aneurysm repair devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The endovascular aneurysm repair devices market size has grown strongly in recent years. It will grow from $2.62 billion in 2025 to $2.83 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to increasing incidence of aortic aneurysms, rising preference for minimally invasive surgeries, expansion of vascular surgery centers, improvements in imaging-guided interventions, availability of advanced catheter technologies.
The endovascular aneurysm repair devices market size is expected to see strong growth in the next few years. It will grow to $3.78 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing adoption of next-generation stent-grafts, rising demand for personalized vascular implants, expansion of endovascular treatment capabilities, growing investments in hybrid operating rooms, increasing focus on long-term patient outcomes. Major trends in the forecast period include increasing adoption of minimally invasive aneurysm repair procedures, rising demand for advanced stent-graft technologies, growing use of image-guided endovascular systems, expansion of customized evar device designs, enhanced focus on procedure precision and safety.
The increasing demand for minimally invasive surgical procedures is expected to drive growth in the endovascular aneurysm repair devices market. Minimally invasive surgeries involve procedures that use specialized tools and techniques with minimal incisions, reducing bodily disruption. The rise in demand for these procedures is due to factors such as faster recovery times, fewer complications, smaller incisions causing less pain, and improved surgical outcomes. Endovascular Aneurysm Repair (EVAR) devices help in these minimally invasive procedures by strengthening blood vessel walls and redirecting blood flow, thereby lowering the risk of aneurysm rupture. For example, in January 2024, Intuitive Surgical Inc., a U.S.-based producer of robotic surgical systems, announced the placement of 415 da Vinci systems in the fourth quarter of 2023, a 12% increase from the previous year. As a result, the growing trend toward minimally invasive surgeries is contributing to the expansion of the endovascular aneurysm repair devices market.
Leading companies in the endovascular aneurysm repair devices market are focusing on developing advanced solutions, such as abdominal stent-graft systems, to improve patient outcomes by enhancing device durability, increasing procedural success rates, and simplifying deployment. An abdominal stent-graft system is a medical device used during endovascular aneurysm repair (EVAR) to treat abdominal aortic aneurysms (AAA). For example, in August 2024, Terumo India, an India-based medical technology company, launched the TREO Abdominal Stent-Graft System, a cutting-edge solution for treating abdominal aortic aneurysms (AAAs) in adults with suitable anatomies. This system features a unique three-piece design that includes both suprarenal and infrarenal active fixation capabilities, enhancing stability and effectiveness during endovascular aneurysm repair (EVAR). Key attributes include in situ limb adjustability for precise deployment, improved proximal sealing to prevent leaks, and superior lock stent technology to minimize migration risks.
In May 2023, Stryker Corporation, a US-based medical technology company, acquired Cerus Endovascular Ltd. for an undisclosed sum. Through this acquisition, Stryker aims to strengthen its portfolio of aneurysm treatment solutions by incorporating innovative neurointerventional devices, enabling physicians to more effectively manage a wider range of intracranial aneurysms. Cerus Endovascular Ltd., also based in the US, specializes in neurovascular medical devices, particularly for the treatment of intracranial aneurysms.
Major companies operating in the endovascular aneurysm repair devices market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic Plc, Royal Philips, Boston Scientific, Terumo Corporation, Biotronik, L. Gore & Associates Inc., AorTech International, Teleflex Incorporated, Getinge AB, Cook Medical Group, Lombard Medical Technologies plc, Merit Medical Systems, Penumbra Inc., Volcano Corporation, Endologix Inc., Medico S.p.A, MicroPort Scientific Corporation
North America was the largest region in the endovascular aneurysm repair devices market in 2025. The regions covered in the endovascular aneurysm repair devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the endovascular aneurysm repair devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The endovascular aneurysm repair devices market consists of sales of stent grafts, delivery systems, guidewires, anchoring devices, and endograft components. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Endovascular Aneurysm Repair Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses endovascular aneurysm repair devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for endovascular aneurysm repair devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The endovascular aneurysm repair devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.